• 北京大學(xué)臨床腫瘤學(xué)院外二科(北京100036);

引用本文： 顧晉,王洪義. 胃癌術(shù)前分期及確定生物學(xué)特性的策略和方法. 中國普外基礎(chǔ)與臨床雜志, 2006, 13(1): 12-14. doi: 復(fù)制

1. 14Yonemura Y, Endou Y, Kimura K, et al. Inverse expression of S100A4 and Ecadherin is associated with metastatic potential in gastric cancer [J]. Clin Cancer Res, 2000; 6(11)∶4234 15Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability [J]. Mod Pathol, 2002; 15(6)∶632.
2. 嚴(yán)仲瑜， 萬遠(yuǎn)廉. 消化道腫瘤外科學(xué) [M]. 北京: 北京大學(xué)醫(yī)學(xué)出版社， 2003∶194~200.
3. 廖盛日， 陳敏華， 霍苓, 等. 體表超生對胃癌浸潤深度的診斷 [J]. 中國超聲雜志， 2003; 19（8）∶601.
4. Akahoshi K, Misawa T, Fujishima H, et al. Regional lymph node metastasis in gastric cancer: evaluation with endoscopic US [J]. Radiology， 1992; 182(2)∶559.
5. Fukuya T, Honda H, Kaneko K, et al. Efficacy of helical CT in Tstaging of gastric cancer [J]. J Comput Assist Tomogr, 1997; 21(1)∶73.
6. Chen J, Cheong JH, Yun MJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography [J]. Cancer, 2005; 103(11)∶2383.
7. Lee DH, Ko YT, Park SJ, et al. Comparison of hydroUS and spiral CT in the staging of gastric cancer [J]. Clin Imaging, 2001; 25(3)∶181.
8. Davies J, Chalmers AG, SueLing HM, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging [J]. Gut， 1997; 41(3)∶314.
9. Marrelli D, Roviello F, De Stefano A, et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection [J]. J Am Coll Surg， 2004; 198(1)∶51.
10. Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA199 in monitoring for recurrence in gastric cancer patients: a prospective clinical study [J]. Gastric Cancer, 2003; 6(3)∶142.
11. Lai IR,Lee WJ,Huang MT,et al.Comparison of serum CA724,CEA,TPA,CA199 and CA125 levels in gastric cancer patients and correlation with recurrence [J]. Hepatogastroenterology, 2002; 49(46)∶1157.
12. Sato T, Nishimura G, Nonomura A, et al. Serological studies on CEA, CA 199, STn and SLX in colorectal cancer [J]. Hepatogastroenterology, 1999; 46(26)∶914.
13. Yonemura Y, Endou Y, Fujita H, et al. Role of MMP7 in the formation of peritoneal dissemination in gastric cancer [J]. Gastric Cancer, 2000; 3(2)∶63.
14. PintodeSousa J, David L, Reis CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinicobiological behaviour of gastric carcinoma [J]. Virchows Arch, 2002; 440(3)∶304.
  1. 1. 14Yonemura Y, Endou Y, Kimura K, et al. Inverse expression of S100A4 and Ecadherin is associated with metastatic potential in gastric cancer [J]. Clin Cancer Res, 2000; 6(11)∶4234 15Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability [J]. Mod Pathol, 2002; 15(6)∶632.
  2. 2. 嚴(yán)仲瑜， 萬遠(yuǎn)廉. 消化道腫瘤外科學(xué) [M]. 北京: 北京大學(xué)醫(yī)學(xué)出版社， 2003∶194~200.
  3. 3. 廖盛日， 陳敏華， 霍苓, 等. 體表超生對胃癌浸潤深度的診斷 [J]. 中國超聲雜志， 2003; 19（8）∶601.
  4. 4. Akahoshi K, Misawa T, Fujishima H, et al. Regional lymph node metastasis in gastric cancer: evaluation with endoscopic US [J]. Radiology， 1992; 182(2)∶559.
  5. 5. Fukuya T, Honda H, Kaneko K, et al. Efficacy of helical CT in Tstaging of gastric cancer [J]. J Comput Assist Tomogr, 1997; 21(1)∶73.
  6. 6. Chen J, Cheong JH, Yun MJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography [J]. Cancer, 2005; 103(11)∶2383.
  7. 7. Lee DH, Ko YT, Park SJ, et al. Comparison of hydroUS and spiral CT in the staging of gastric cancer [J]. Clin Imaging, 2001; 25(3)∶181.
  8. 8. Davies J, Chalmers AG, SueLing HM, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging [J]. Gut， 1997; 41(3)∶314.
  9. 9. Marrelli D, Roviello F, De Stefano A, et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection [J]. J Am Coll Surg， 2004; 198(1)∶51.
  10. 10. Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA199 in monitoring for recurrence in gastric cancer patients: a prospective clinical study [J]. Gastric Cancer, 2003; 6(3)∶142.
  11. 11. Lai IR,Lee WJ,Huang MT,et al.Comparison of serum CA724,CEA,TPA,CA199 and CA125 levels in gastric cancer patients and correlation with recurrence [J]. Hepatogastroenterology, 2002; 49(46)∶1157.
  12. 12. Sato T, Nishimura G, Nonomura A, et al. Serological studies on CEA, CA 199, STn and SLX in colorectal cancer [J]. Hepatogastroenterology, 1999; 46(26)∶914.
  13. 13. Yonemura Y, Endou Y, Fujita H, et al. Role of MMP7 in the formation of peritoneal dissemination in gastric cancer [J]. Gastric Cancer, 2000; 3(2)∶63.
  14. 14. PintodeSousa J, David L, Reis CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinicobiological behaviour of gastric carcinoma [J]. Virchows Arch, 2002; 440(3)∶304.